DOI: 10.4244/EIJV12I3A65

Microprobe transoesophageal echocardiographic guidance during transcatheter interatrial septal device implantation in heart failure with a preserved ejection fraction

Roel J.R. Snijder*, MD; Martin J. Swaans, MD, PhD; Jan A.S. van der Heyden, MD, PhD; Martijn C. Post, MD, PhD

Ao: aorta; LA: left atrium; RA: right atrium; SVC: superior vena cava

A 73-year-old male with a history of transient ischaemic attack, paroxysmal atrial fibrillation and heart failure with a preserved ejection fraction (HFPEF) was seen in the outpatient clinic with severe symptoms of heart failure despite optimal medical therapy. Prior to study inclusion (REDUCE-LAP trial) a heart catheterisation had been performed. The coronary angiogram showed only a significant stenosis of a small ramus descendens posterior.

Pulmonary hypertension (mean pulmonary artery pressure 34 mmHg) with an increased wedge pressure (21 mmHg) was present. The patient gave informed consent and was accepted for interatrial septal device (IASD®; DC Devices, Inc., Tewksbury, MA, USA) implantation in order to lower left atrial pressure. The procedure was performed under local anaesthesia and microprobe transoesophageal echocardiography (mTEE) guidance (S8-3t sector array multiplane microTEE; Philips Healthcare, Best, The Netherlands). A transseptal puncture via the transfemoral access was performed as seen in the mid-oesophageal bicaval view in Panel A (arrow). Subsequently, the IASD was implanted with the occurrence of a continuous left-to-right atrial flow through the device. Panel B shows, using the mid-oesophageal short-axis at the base view, the implanted IASD with left-to-right flow using colour Doppler (arrows). Panel C indicates permanent left-to-right shunt using continuous wave Doppler. The per-procedural fluoroscopic image (Panel D) shows the IASD and the microprobe (respectively black and white arrow).

The procedure and hospitalisation were uncomplicated. The use of mTEE was easy and safe. The handling of the mTEE probe was similar when compared to standard TEE. Though the images from the mTEE had a lower resolution, they were good enough for transcatheter (atrial) intervention, such as IASD implantation. All necessary views could be recorded, except for three-dimensional images.

Conflict of interest statement

The authors have no conflicts of interest to declare.

Volume 12 Number 3
Jun 20, 2016
Volume 12 Number 3
View full issue

Key metrics

On the same subject

10.4244/EIJV12SXA17 May 16, 2016
Creating interatrial shunts in heart failure and pulmonary hypertension
Wolsk E and Gustafsson F

Expert review

10.4244/EIJ-D-18-01211 Jun 20, 2019
Interatrial shunting for heart failure: current evidence and future perspectives
Guimarães L et al


10.4244/EIJY15M07_08 Oct 20, 2015
Implantable atrial flow regulator for severe, irreversible pulmonary arterial hypertension
Patel M et al

Image – Interventional flashlight

10.4244/EIJ-D-19-00873 Aug 28, 2020
A novel implantable left atrial sensor for pressure monitoring in heart failure
Di Mario C et al


10.4244/EIJ-D-17-00164 Jun 20, 2017
First transjugular edge-to-edge mitral valve repair with the MitraClip system
Fam N et al
Trending articles

Translational research

10.4244/EIJ-D-21-00824 May 15, 2022
Bench test and in vivo evaluation of longitudinal stent deformation during proximal optimisation
Toth GG et al

Expert review

10.4244/EIJ-D-21-00690 May 15, 2022
Crush techniques for percutaneous coronary intervention of bifurcation lesions
Moroni F et al


10.4244/EIJ-D-22-00776 Apr 3, 2023
Computed tomographic angiography in coronary artery disease
Serruys PW et al


10.4244/EIJ-E-22-00007 May 15, 2022
TAVI at 20: how a crazy idea led to a clinical revolution
Eltchaninoff H et al

Expert consensus

10.4244/EIJ-E-22-00018 Dec 4, 2023
Definitions and Standardized Endpoints for Treatment of Coronary Bifurcations
Lunardi M et al

State of the art

10.4244/EIJ-D-22-00969 Jun 19, 2023
Functional coronary angiography for the assessment of the epicardial vessels and the microcirculation
Faria D et al

The Official Journal of EuroPCR and the European Association of Percutaneous Cardiovascular Interventions (EAPCI)

Impact factor: 6.2
2022 Journal Citation Reports®
Science Edition (Clarivate Analytics, 2023)
Online ISSN 1969-6213 - Print ISSN 1774-024X
© 2005-2024 Europa Group - All rights reserved